Karen Dybkær

Karen Dybkær is a Professor and Senior Researcher at Aalborg University Hospital's Clinical Institute within the Faculty of Health Sciences at Aalborg University, specializing in the Department of Blood Diseases. Her research focuses on hematological malignancies with particular emphasis on blood cancers and biomarker discovery.

Her primary research interests include Diffuse Large B-Cell Lymphoma, B Cell Immunology, Multiple Myeloma, and gene expression profiling as evidenced by her extensive publication record. The fingerprint analysis of her work shows strong focus areas in Diffuse Large B-Cell Lymphoma (100%), B Cell Immunology (88%), and Multiple Myeloma (16%).

Dr. Dybkær's recent publication trends (2021-2025) show continued productivity with significant contributions to understanding cancer biomarkers, treatment response mechanisms, and molecular profiling in hematological malignancies. Her work spans both basic science and clinical applications, with publications appearing in high-impact journals across hematology and oncology.

She has been actively involved in PhD supervision, having mentored 6 doctoral students according to institutional records. Her collaborative research extends across Nordic countries with significant involvement in the Nordic Myeloma Study Group and other international hematology research networks.

Dr. Dybkær maintains active engagement with patient communities, as evidenced by her participation in events like the Lyle patient association for lymphoma and leukemia. Her research has received media attention in Denmark, particularly regarding new initiatives in cancer research and her appointment as professor in hematology in 2021.